Please assess the completion status of the following clinical trial:

Trial Title: Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Above 21 year old~2. OGD done within 48 hrs of admission~3. No recent upper GIT surgery past one month~4. Forrest Type I, IIa \& IIb ulcer (Type Ia: Spurting, Ib:Oozing, IIa: Visible vessel, IIb: Clot)~5. Non-malignant ulcer~6. Informed consent taken~Exclusion Criteria:~1. Impaired hepatic function~2. Pregnancy~3. Lactation~4. Concomitant medication (warfarin, diazepam, phenytoin, chlarithromycin, cimetidine and digoxin)~5. Underlying malignancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: ACTIVE_COMPARATOR): regular dose versus high dose

Based on this trial design, predict the completion outcome and termination type (if applicable).